Petros Pharmaceuticals, Inc. Current Assets
Petros Pharmaceuticals, Inc. (PTPI) had Current Assets of $3.55 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $3.55M.
- 2026-03-31: Assets, Current $4.39M.
- 2025-12-31: Assets, Current $5.16M.
- 2025-09-30: Assets, Current $6.13M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $3.55M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.39M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $5.16M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $6.13M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $7.40M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $14.47M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $7.29M 10-K · filed 2026-04-15 |
| 2024-09-30 | $10.72M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $13.98M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $17.90M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $20.39M 10-K · filed 2025-03-31 |
| 2023-09-30 | $24.43M 10-Q · filed 2023-11-15 |
| 2023-06-30 | $13.15M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $13.90M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $14.67M 10-K · filed 2024-04-01 |
| 2022-09-30 | $18.77M 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | $22.85M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $26.84M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $30.54M 10-K · filed 2023-03-31 |
| 2021-09-30 | $13.35M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $16.23M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $23.96M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $25.91M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |